Medicinal products incorporating bound organosulfur groups
US8217084B2 · kind B2 · utility
8Cited by
4References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 24, 2005 |
| Grant date | Jul 10, 2012 |
| Priority date | — |
| Expiry date | May 24, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/8962
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nutraceutical and dietary supplement formulations for delivering bioavailable thiols to a host, comprising certain organosulfur radicals, such as the allyl mercapto radical, bound to larger molecules such as proteins, resulting in the formation in the host's body of various allium-related compounds such as allicin. The formulations are produced by treating an ingestible material comprising a cysteine-containing protein with a thiol, disulfide, mixed disulfide, thiosufinate or mixed thiosulfinate so as to cause thiol residues to become disulfide bonded to cysteines contained in the protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.